249 related articles for article (PubMed ID: 29432868)
1. Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
Mohammad H; AbdelKhalek A; Abutaleb NS; Seleem MN
Int J Antimicrob Agents; 2018 Jun; 51(6):897-904. PubMed ID: 29432868
[TBL] [Abstract][Full Text] [Related]
2. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.
AbdelKhalek A; Abutaleb NS; Elmagarmid KA; Seleem MN
Sci Rep; 2018 May; 8(1):8353. PubMed ID: 29844350
[TBL] [Abstract][Full Text] [Related]
3. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
AbdelKhalek A; Abutaleb NS; Mohammad H; Seleem MN
PLoS One; 2018; 13(6):e0199710. PubMed ID: 29953486
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
5. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
Rajamuthiah R; Fuchs BB; Conery AL; Kim W; Jayamani E; Kwon B; Ausubel FM; Mylonakis E
PLoS One; 2015; 10(4):e0124595. PubMed ID: 25897961
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
Abamecha A; Wondafrash B; Abdissa A
BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
[TBL] [Abstract][Full Text] [Related]
7. Detection of vancomycin resistance in enterococcus species isolated from clinical samples and feces of colonized patients by phenotypic and genotypic methods.
Biswas PP; Dey S; Adhikari L; Sen A
Indian J Pathol Microbiol; 2016; 59(2):188-93. PubMed ID: 27166038
[TBL] [Abstract][Full Text] [Related]
8. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus.
Kim SG; Becattini S; Moody TU; Shliaha PV; Littmann ER; Seok R; Gjonbalaj M; Eaton V; Fontana E; Amoretti L; Wright R; Caballero S; Wang ZX; Jung HJ; Morjaria SM; Leiner IM; Qin W; Ramos RJJF; Cross JR; Narushima S; Honda K; Peled JU; Hendrickson RC; Taur Y; van den Brink MRM; Pamer EG
Nature; 2019 Aug; 572(7771):665-669. PubMed ID: 31435014
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of linezolid against vancomycin resistant Enterococci.
Hussain MS; Sattar A; Hussain M
Pak J Pharm Sci; 2018 Sep; 31(5):1853-1857. PubMed ID: 30150180
[TBL] [Abstract][Full Text] [Related]
10. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium.
Caballero S; Kim S; Carter RA; Leiner IM; Sušac B; Miller L; Kim GJ; Ling L; Pamer EG
Cell Host Microbe; 2017 May; 21(5):592-602.e4. PubMed ID: 28494240
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.
Kauffman CA
J Antimicrob Chemother; 2003 Jun; 51 Suppl 3():iii23-30. PubMed ID: 12801939
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.
Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):2144-8. PubMed ID: 15155213
[TBL] [Abstract][Full Text] [Related]
14. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
Li F; Wang Y; Sun L; Wang X
BMC Infect Dis; 2020 Feb; 20(1):167. PubMed ID: 32087689
[TBL] [Abstract][Full Text] [Related]
16. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
[TBL] [Abstract][Full Text] [Related]
17. A novel high-resolution melting analysis approach for rapid detection of vancomycin-resistant enterococci.
Ozbak HA
Ann Saudi Med; 2018; 38(3):200-207. PubMed ID: 29848938
[TBL] [Abstract][Full Text] [Related]
18. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
19. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
[TBL] [Abstract][Full Text] [Related]
20. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates.
Goossens H; Jabes D; Rossi R; Lammens C; Privitera G; Courvalin P
J Antimicrob Chemother; 2003 Jun; 51 Suppl 3():iii5-12. PubMed ID: 12801937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
